Square Pharmaceuticals PLC. (DSE:SQURPHARMA)

Market Cap	189.79B
Revenue (ttm)	75.17B
Net Income (ttm)	23.50B
Shares Out	886.45M
EPS (ttm)	26.52
PE Ratio	8.07
Forward PE	7.84
Dividend	11.00 (5.14%)
Ex-Dividend Date	Nov 24, 2024

Volume	110,420
Average Volume	229,175
Open	215.60
Previous Close	215.00
Day's Range	213.90 - 216.00
52-Week Range	197.20 - 249.80
Beta	0.16
RSI	37.89
Earnings Date	Apr 30, 2025

About DSE:SQURPHARMA

Square Pharmaceuticals PLC., together with its subsidiaries, manufactures, markets, and sells pharmaceutical products in Bangladesh and internationally. The company offers pharmaceutical products comprising alimentary preparations, amoebocides, analgesics, anti-aphthous ulcer, anti-erectile dysfunction, anti-gout, anti-hyperkalemia, anti-osteoarthritis, anti-thyroid, anti-ulcerants, anthelmintics, antiallergies, antianemics, antiasthma, antibiotics, antidiabetics, antifibrinolytics, antihemorrhoidals, antihistamines, antiosteoporotics, antioxid...

• Industry: Pharmaceutical Preparations
• Founded: 1958
• Employees: 12,453
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: SQURPHARMA

Financial Performance

In 2024, DSE:SQURPHARMA's revenue was 70.10 billion, an increase of 15.47% compared to the previous year's 60.71 billion. Earnings were 20.93 billion, an increase of 10.25%.